Confirmed Speakers

5th International RASopathies Symposium:
Where Development and Cancer Intersect

July 28-30, 2017 ~ Orlando, FL

Chairs

  • Frank McCormick, PhD, FRS,DSc (Hon), Director, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA and Consultant, National Cancer Institute, Fredrick, MD
  • Katherine A. Rauen, MD, PhD, Chief, Division of Genomic Medicine, and Professor, University of California, Davis, CA

Speakers and Moderators

  • John Albeck, PhD, University of California, Davis, CA
  • Brage Storstein Andresen, PhD, FRCPath, Professor, University of Southern Denmark, Odense, Denmark
  • Ashley Cannon, PhD MS CGC, University of Alabama, Birmingham, AL
  • Hélène Cavé, PharmD, PhD, Professor, Université Paris Diderot, Robert-Debré University Hospital, France
  • Michelle Ellis, Noonan Syndrome UK
  • Steven Fruchtman, MD, Onconova
  • Bruce Gelb, MD, Professor, Director, Mindich Child Health and Development Institute, Mount Sinai Hospital, Icahn School of Medicine, NY
  • Christopher Gibson, PhD, Co-Founder and CEO, Recursion Pharmaceuticals
  • Karen Gripp, MD, Professor, Nemours, duPont Hospital for Children, DE
  • Jay Groves, PhD, Professor, University of California, Berkeley, CA
  • Rick Guidotti, Positive Exposure
  • Erin Heffner, Costello Syndrome Family Network
  • William Huang, PhD, University of California, Berkeley, CA
  • Maxim Itkin, MD, Associate Professor, University of Pennsylvania, Perelman School of Medicine
  • Bronwyn Kerr, MBBS, Faculty, Honorary Lecturer, Consultant Geneticist, Manchester University Hospital, Manchester, UK
  • Corinne Linardic, MD, PhD, Associate Professor, Duke University, NC
  • Martin McMahon, PhD, Professor, University of Utah, Huntsman Cancer Institute, UT
  • Bev Oberlander, NF Network
  • Ethan Perlstein, PhD, CEO, Perlara, San Francisco, CA
  • Nancy Ratner, PhD, Professor, Cincinnati Children’s Hospital, OH
  • Amy Roberts, MD, Assistant Professor, Boston Children’s Hospital, Harvard Medical School, MA (Director, RASopathies Symposium Junior Investigator Grants Program)
  • Nancy Ratner, PhD, Cincinnati Children’s Hospital Medical Center, OH
  • Leslie Rogers, CFC International
  • Annette Schenck, PhD, Associate Professor, Radboud UMC, Nijmegen, Netherlands
  • Suma Shankar, MD, PhD, Associate Professor, University of California at Davis, CA
  • Lisa Schill, BS, Vice President, RASopathiesNet, NJ
  • Lisa Schoyer, MFA, Founder and President, RASopathiesNet, CA
  • Suma Shankar, MD, PhD, University of California at Davis, CA
  • Stanislav Shvartsman, PhD, Professor, Princeton University
  • David A. Stevenson, MD, Associate Professor, Stanford University, Lucile Salter Packard Children’s Hospital, CA
  • Edward Stites, MD, PhD, Assistant Professor, Salk Institute, CA
  • Philip Stork, MD, Senior Scientist, Oregon Health & Science University, Vollum Institute, OR
  • Beth Stronach, PhD, Boardmember, RASopathiesNet, PA
  • Cheng Sun, PhD (Kontaridis Lab), Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
  • Marc Therrien, PhD, Professor, University of Montreal, Institute Research Immunology and Cancer (IRIC), Canada
  • William Timmer, PhD, National Cancer Institute, Bethesda, MD
  • Erik Ullian, PhD, University of California, San Francisco, CA
  • Brigitte Widemann, MD, Senior Investigator, National Cancer Institute, CCR, Bethesda, MD
  • Erika Yeh, PhD, (Weiss Lab) University of California, San Francisco (UCSF), CA
  • Giuseppe Zampino, MD, Associate Professor, Catholic University (UCSC), Rome, Italy
  • Martin Zenker, MD, Professor, Otto-von-Guericke U, Institute of Human Genetics, Magdeburg, Germany